IMPACT BIOMEDICAL INC. business relationships
Companies named in IMPACT BIOMEDICAL INC.’s 10-K filed 2026-03-11, and public companies whose annual reports name IMPACT BIOMEDICAL INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 26 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in IMPACT BIOMEDICAL INC.’s annual report 2
“addition to utilizing the Microsoft cloud ecosystem, we have engaged a third-party service provider to enhance our cybersecurity posture” SEC filing
“| License Agreement with ProPhase Labs, Inc. dated July 18, 2022 incorporated by reference to Exhibit 10.18 to the Company's Amendment to the Registration Statement on Form S-1 (No. 333- 275062 ) filed with the SEC on November 21, 2023. |” SEC filing
Companies whose annual reports name IMPACT BIOMEDICAL INC. 1
“Agreement - On March 19, 2022, Impact BioMedical entered into a License Agreement ("Equivir License") with” SEC filing
Links are read automatically from public company filings, so every link carries the sentence it came from.
Not investment advice. Scores, rankings and connections are automated estimates from public sources, provided as is. Connections are read automatically from public company filings and may be incomplete or wrong. To correct or remove a company page or a connection, email [email protected]. Company names and logos belong to their owners. Showing them does not mean the company endorses Engagemii or that Engagemii endorses it. Terms